• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

Request the impact of COVID-19 in this market at no additional cost. Buy it today to get an advantage.

Request Now


The global diabetes drug market experienced robust growth over the last five years and is expected to witness good growth by reaching approximately US $56.9 billion in 2018 with a CAGR of 6.5% over next five years. A growing middle class population, changing demographic profile, increase in number of consumers with medical insurance, expanding economy, and increasing GDP per capita are expected to provide enormous opportunities for diabetes drug manufacturers in the Asia Pacific (APAC) region.


As per the study, there are several major drivers in the manufacturing area: growing per capita income and GDP with more government support, increasing diabetes cases, increased awareness, and changing demographics. The objective of all the strategies is discovery, manufacture, and commercialization of products that match the industry demands with regard to type, time, place, and price.

A total of 48 figures / charts and 12 tables are provided in this report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of the diabetes drug market
 report, download the report brochure.
Diabetes Drugs Market Trends
Diabetes Drugs Market ForecastDiabetes Drugs Market Cost Structure
A combination of factors such as technology innovations, medical insurance coverage, rising income, aging population, and changing lifestyle greatly affect industry dynamics. The industry registered 10.9% growth in 2012 due to rapidly aging population and regulators’ efforts to increase healthcare access to its population. An expanding patient pool and changes in treatment patterns have resulted in growth for the diabetes drugs industry.

The diabetes drug market is highly consolidated with all classes of drugs used for the treatment of diabetes. North America dominates this industry, as the region is the largest consumer of diabetes drugs and represented 41.3% of the global diabetes drugs industry in 2012.

Lucintel’s research indicates that APAC holds good growth potential for the future as India is expected to play an important role in the global economy. Demand from a growing population continues to drive consumption for diabetes drugs. Major pharmaceuticals companies are planning to invest in the Asian markets to gain market share for diabetes drugs.

Some of the features of Growth Opportunities in the Global Diabetes Drug Market report are:

•    Diabetes drug market size estimates in terms of (US $) value by regions and segments
•    Global diabetes drug market analysis annual  trend (2007-2012) and forecast (2013-2018)
•    Porter’s Five Force analysis
•    New product launch and merger and acquisition activity in global diabetes drug market analysis
•    Quarterly demand trend (Q1 2011-Q4 2012) and forecast analysis (Q1 2013-Q4 2014) for global diabetes drugs industry analysis
•    Gross and net profit trends in the global diabetes drug market analysis
•    Cost structure trend in the global as well as regional diabetes drugs analysis
•    More than 48 valuable figures/charts and 12 tables are provided in this report
 

Table of Contents

 1. Executive Summary 
 2. Industry Definition and Scope 
 3. Industry Overview 
 4. Global Macroeconomic Overview 
 5. Industry Trends 
 6. Industry Forecasts 
 7. Performance Gap 
 8. Conclusions  


List of Figures
 
Chapter 3. Industry Overview
Figure 3.1: External forces shaping global diabetes drugs industry
 
Chapter 4. Global Macroeconomic Overview
Figure 4.1: Global GDP growth rate trend
Figure 4.2: Global inflation rate trend
Figure 4.3: Global population growth rate trend
Figure 4.4: Global unemployment rate trend
Figure 4.5: Regional GDP growth rate trend
Figure 4.6: Regional inflation rate trend
Figure 4.7: Regional population growth rate trend
Figure 4.8: Regional unemployment rate trend
 
Chapter 5. Industry Trends
Figure 5.1: Global diabetes drugs industry annual trend 2007-12 (US $B)
Figure 5.2: Global diabetes drugs industry regional trend 2007-12 (US $B)
Figure 5.3: Global diabetes drugs industry regional trend 2007-12 (%)
Figure 5.4: Global diabetes drugs industry segment trend 2007-12 (US $B)
Figure 5.5: Global diabetes drugs industry segment trend 2007-12 (%)
Figure 5.6: Global diabetes drugs industry quarterly trend 2010-11 (US $B)
Figure 5.7: Global diabetes drugs industry profitability trend 2007-12
Figure 5.8: Global diabetes drugs industry revenue per employee Trend 2007-12
Figure 5.9: Cost structure of global diabetes drugs industry 2007-12
Figure 5.10: Cost structure in North American diabetes drugs industry 2007-12
Figure 5.11: Cost structure in European diabetes drugs industry 2007-12
Figure 5.12: Cost structure in Asia Pacific diabetes drugs industry 2007-12
Figure 5.13: Top 5 companies vs. diabetes drugs industry gross profit & net profit analysis 2012
Figure 5.14: Cash on hand for global diabetes drugs industry 2007-12 (US $B)
Figure 5.15: Cash on hand for global diabetes drugs industry 2007-12 (%)
Figure 5.16: Asset for global diabetes drugs industry 2007-12 (US $B)
Figure 5.17: Assets for global diabetes drugs industry 2007-12 (%)
Figure 5.18: Debt for global diabetes drugs industry 2007-12 (US $B)
Figure 5.19: Debt for global diabetes drugs industry 2007-12 (%)
Figure 5.20: Industry shares of top players in global diabetes drugs industry in 2007
Figure 5.21: Industry shares of top players in global diabetes drugs industry in 2012
Figure 5.22: Global diabetes drugs industry 2007 market share analysis
Figure 5.23: Global diabetes drugs industry 2012 market share analysis
 
Chapter 6. Industry Forecasts
Figure 6.1: Global diabetes drugs industry annual forecast 2013-18 (US $B)
Figure 6.2: Global diabetes drugs industry quarterly forecast 2013-14 (US $B)
Figure 6.3: Global GDP growth rate forecast
Figure 6.4: Global inflation rate forecast
Figure 6.5: Global population growth rate forecast
Figure 6.6: Global unemployment rate forecast
Figure 6.7: Regional GDP growth rate forecast
Figure 6.8: Regional inflation rate forecast
Figure 6.9: Regional population growth rate forecast
Figure 6.10: Regional unemployment rate forecast
Figure 6.11: Global diabetes drugs industry regional forecast 2013-18 (US $B)
Figure 6.12: Global diabetes drugs industry regional forecast 2013-18 (%)
Figure 6.13: Global diabetes drugs industry segment forecast 2013-18 (US $B)
Figure 6.14: Global diabetes drugs industry segment forecast 2013-18 (%)
 
Chapter 7. Emerging Trends
Figure 7.1: Global diabetes drugs industry opportunity by region
Figure 7.2: Global diabetes drugs industry opportunity by segment
 
List of Tables
 
Chapter 3. Industry Overview
Table 3.1: Industry parameters of global diabetes drugs industry
Table 3.2: Relative industry attractiveness by region
 
Chapter 5. Industry Trends
Table 5.1: Regional revenue growth rate
Table 5.2: Segment revenue growth rate
Table 5.3: Percentage change in cost structure
Table 5.4: Percentage change in cash on hand
Table 5.5: Percentage change in total asset  
Table 5.6: Percentage change in total debt
Table 5.7: Key companies by revenue growth
Table 5.8: Key companies by revenue decline
 
Chapter 6. Industry Forecasts
Table 6.1: Global diabetes drugs regional forecast growth rate
Table 6.2: Global diabetes drugs segment forecast growth rate
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Diabetes Drugs Market: Market Size, Trends and Growth Analysis Full Report $ 1,980
More than 48 valuable figures/charts and 12 tables are provided in this report
 
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served 1,000+ clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive search of published works, market and database information with industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted in the supply chain of this market to estimate market share, market size, trends, drivers, challenges and forecasts in the market. Below is a brief summary of primary interviews conducted by both job function and region.


Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis on it. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of the Lucintel research process.

 

Please sign in below to get report brochure - Diabetes Drugs Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )